GPR55 and Impaired glucose tolerance: Recent studies show that the LPI/GPR55 system is a novel target for obesity with both normal or impaired glucose tolerance and type 2 diabetes, and a significant increase in circulating plasma LPI levels was observed in obese individuals58.